Wiener medizinische Wochenschrift最新文献

Comparing the portrayal of #autism and #neurodiversity on TikTok: creators, content, and representation.

IF 1.1

Wiener medizinische Wochenschrift Pub Date : 2025-03-11 DOI: 10.1007/s10354-025-01076-w

Verena Steiner-Hofbauer, Yvette Annabel Pintér, Gloria Mittmann

{"title":"Comparing the portrayal of #autism and #neurodiversity on TikTok: creators, content, and representation.","authors":"Verena Steiner-Hofbauer, Yvette Annabel Pintér, Gloria Mittmann","doi":"10.1007/s10354-025-01076-w","DOIUrl":"https://doi.org/10.1007/s10354-025-01076-w","url":null,"abstract":"Background: Social media is a significant source of information on health-related topics and neurodevelopmental disorders such as autism spectrum disorder (ASD). The public perception of ASD, as reflected on social media, can raise awareness but also increase stigma. This study examined ASD portrayal on TikTok, focusing on neurodiversity, content themes, creator identities, and the depiction of autistic individuals.Materials and methods: This exploratory study analyzed 100 TikTok videos: the 50 most-watched for #autism and the 50 most-watched for both #autism and #neurodiversity. The study reviewed metadata and content using publicly available data.Results: Videos from the #autism sample encompassed 97% of all views and primarily portrayed entertaining content. Neurodiversity videos were more educational and less popular. Creators and portrayed individuals were primarily white. Adult autistic individuals are more ferequently represented in the #neurodiversity sample (30%), but children sill appear frequently (30% in the # neurodiversity and 38% in the #autism sample). Healthcare professionals (HCPs) were absent in the autism sample but appeared in 32% of neurodiversity videos.Conclusion: The portrayal of ASD differed widely in both samples. Both samples underrepresented ethnic minorities. As TikTok shapes public perception of ASD, HCPs should be aware of trending ASD-related content on TikTok in order to be able to combat misinformation.","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143605531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Acquired digital periungual fibrokeratoma in a 36-year-old male: case report and an update.

IF 1.1

Wiener medizinische Wochenschrift Pub Date : 2025-03-10 DOI: 10.1007/s10354-025-01073-z

G Tchernev, D Linkwinstar, A Shine, V Broshtilova, S Kordeva

{"title":"Acquired digital periungual fibrokeratoma in a 36-year-old male: case report and an update.","authors":"G Tchernev, D Linkwinstar, A Shine, V Broshtilova, S Kordeva","doi":"10.1007/s10354-025-01073-z","DOIUrl":"https://doi.org/10.1007/s10354-025-01073-z","url":null,"abstract":"Acquired digital fibrokeratoma (ADFK) is a rare benign mesenchymal tumor often presenting as a small, firm, hyperkeratotic lesion, typically located in the periungual or subungual regions of the digits. Though benign, ADFK can lead to significant functional or cosmetic issues and may be mistaken for more serious conditions such as squamous cell carcinoma or pyogenic granuloma. We report the case of a 36-year-old male with a 3- to 4‑year history of a progressively enlarging periungual tumor leading to nail deformity and mild pressure effects on the underlying bone. The patient's history included minor trauma, possibly contributing to the lesion's development. Dermatological and histopathological evaluations revealed a well-demarcated mesenchymal lesion with orthohyperkeratosis, irregular acanthosis, and stellate fibroblasts within a vascular stroma, consistent with ADFK. A CT scan confirmed mild deformity of the distal phalanx but no bone infiltration. Surgical excision was offered but deferred by the patient, who preferred monitoring of the lesion. This case highlights the importance of accurate diagnosis through clinical, histopathological, and imaging evaluations to distinguish ADFK from other periungual tumors and underscores the need for individualized treatment based on patient preferences and the lesion's impact.","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143597915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Monitoring analysis of the use of biosimilar medicines in the Campania region (southern Italy) to support effective and sustainable care.

IF 1.1

Wiener medizinische Wochenschrift Pub Date : 2025-03-05 DOI: 10.1007/s10354-025-01071-1

Francesco Ferrara, Andrea Zovi, Roberto Langella, Maurizio Capuozzo

{"title":"Monitoring analysis of the use of biosimilar medicines in the Campania region (southern Italy) to support effective and sustainable care.","authors":"Francesco Ferrara, Andrea Zovi, Roberto Langella, Maurizio Capuozzo","doi":"10.1007/s10354-025-01071-1","DOIUrl":"https://doi.org/10.1007/s10354-025-01071-1","url":null,"abstract":"Background: Biosimilar drugs offer a valuable opportunity for healthcare systems worldwide, providing significant cost savings and ensuring the same level of effectiveness and safety in the treatment of chronic conditions. These savings can be reinvested into continuous medical innovations.Methods: A search was carried out to assess the use of key biosimilar medications across various therapeutic areas within an Italian health authority that serves a population of over 1 million people. Data on usage, costs, and the number of patients treated were obtained from the company databases. In addition, a comparison with the year 2022 was performed, aiming to identify any increase in the use of biosimilar drugs during 2023.Results: The analysis of 2023 revealed that a large majority of the studied active ingredients are administered as biosimilar medications, with only a few exceptions. Resistance remains in the prescription of adalimumab and etanercept, with spending on the originators of close to 3 million euros.Conclusion: The comparison between 2023 and 2022 highlighted the growing adoption of biosimilar medications. This positive trend suggests the potential for achieving full utilization in the near future. Such a result would significantly benefit the national healthcare system and the public, ensuring a healthcare approach that is both effective and sustainable.","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143558217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Features of TP53-mutated patients with chronic myelomonocytic leukemia in a national (ABCMML) and international cohort (cBIOPORTAL).

IF 1.1

Wiener medizinische Wochenschrift Pub Date : 2025-03-05 DOI: 10.1007/s10354-025-01072-0

Magdalena Grass, Klaus Geissler

引用次数: 0

Intravitreal therapy-success stories and challenges.

IF 1.1

Wiener medizinische Wochenschrift Pub Date : 2025-03-03 DOI: 10.1007/s10354-024-01070-8

Daniel Egger, Katharina A Heger, Matthias Bolz, Max P Brinkmann, Katharina Krepler, Pia Veronika Vecsei-Marlovits, Andreas Wedrich, Sebastian M Waldstein

{"title":"Intravitreal therapy-success stories and challenges.","authors":"Daniel Egger, Katharina A Heger, Matthias Bolz, Max P Brinkmann, Katharina Krepler, Pia Veronika Vecsei-Marlovits, Andreas Wedrich, Sebastian M Waldstein","doi":"10.1007/s10354-024-01070-8","DOIUrl":"https://doi.org/10.1007/s10354-024-01070-8","url":null,"abstract":"Intravitreal injections have revolutionized the treatment of various sight-threatening diseases of the posterior segment of the eye. Initially explored for treatment of bacterial endophthalmitis, intravitreal injections rapidly expanded to combat retinal vascular disease in particular. Especially anti-vascular endothelial growth factor agents have emerged as a cornerstone of intravitreal therapy, targeting neovascular age-related macular degeneration and diabetic macular edema as important examples. Advances continue, with novel therapies such as complement inhibitors now available as treatment for geographic atrophy secondary to non-neovascular age-related macular degeneration, offering hope for a previously untreatable condition. Pioneering approaches such as the port delivery system and intravitreal gene therapy aim to improve treatment efficacy while minimizing patient burden. Despite notable successes, challenges for intravitreal therapies persist, including ocular and systemic complications and high treatment burden. Future research endeavors aim to address these challenges and enhance treatment outcomes. This comprehensive review critically evaluates the efficacy, safety, and cost-effectiveness of intravitreal injections, delving into emerging trends and future directions.","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Scurvy-A now forgotten previously widespread disease]. [坏血病--一种现在已被遗忘的、以前很普遍的疾病]。

IF 1.1

Wiener medizinische Wochenschrift Pub Date : 2025-03-01 Epub Date: 2024-10-16 DOI: 10.1007/s10354-024-01054-8

Heinz Flamm

{"title":"[Scurvy-A now forgotten previously widespread disease].","authors":"Heinz Flamm","doi":"10.1007/s10354-024-01054-8","DOIUrl":"10.1007/s10354-024-01054-8","url":null,"abstract":"From the sea voyages of the fifteenth century often lasting for years with provisions only of fish, salted meat and biscuits reports came of fatal health alterations of the seamen which were characterized by prostration, loss of teeth and bad breath.Reports on comparable endemic illnesses soon came from the Netherlands, North Germany, the Baltic area, France, Lorraine, Geneva, Bohemia, Moravia, Silesia, Swabia and Russia: the so-called land scurvy. The first medical specification was found in a letter from 1541 by Johann Echt to colleges in the area of Lower Germany, which was published four times. One of the first comprehensive considerations was prepared by the English physician James Lind. Scurvy was also mostly published under many local names, such as Skorbut, Scharbock or Scheurbuik.The pathology of scurvy is dominated by gingival necrosis with loss of teeth, hemorrhages with destruction of the cartilage-bone border especially of the ribs and by subperiosteal hemorrhages of the ribs and long bones.For treatment and prevention of scurvy eating green plants as originally Ficaria verna (lesser celandine, pilewort), Chelidonium majus (great celandine, nipplewort, tetterwort) and Cochlearia officinalis (scurvy grass) proved to be effective. Where green plants were missing decoctions of conifer needles and fresh animal innards were used. When the infantile disease originally named \"acute rachitis\" in England was diagnosed as scurvy (later Möller-Barlow disease) the treatment of cow's milk for baby food became of great interest.Finally, hexuronic acid, later called ascorbic acid or vitamin C, was found to be a drug that could easily dosed for curing and prevention of scurvy.","PeriodicalId":23882,"journal":{"name":"Wiener medizinische Wochenschrift","volume":" ","pages":"75-97"},"PeriodicalIF":1.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142476167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Assassination of Elisabeth, Empress of Austria, Queen of Hungary, on 10 September 1898: further additions and minor annotations. 1898 年 9 月 10 日奥地利皇后、匈牙利王后伊丽莎白遇刺：进一步补充和少量注释。

IF 1.1

Wiener medizinische Wochenschrift Pub Date : 2025-03-01 Epub Date: 2024-09-13 DOI: 10.1007/s10354-024-01053-9

Andreas G Nerlich, Roland Sedivy, Michael E Habicht, Francesco M Galassi, Simon Donell, Viktoria Bogner-Flatz, Oliver K Peschel

引用次数: 0

[The Topical Collection in Wiener Medizinische Wochenschrift].

IF 1.1

Wiener medizinische Wochenschrift Pub Date : 2025-03-01 Epub Date: 2025-03-07 DOI: 10.1007/s10354-025-01075-x

Herbert Kurz

引用次数: 0

Alcohol and the death of Ludwig van Beethoven: comparison of general biographies to the medical literature. 酒精与路德维希·凡·贝多芬之死:一般传记与医学文献的比较。

IF 1.1

Wiener medizinische Wochenschrift Pub Date : 2025-03-01 Epub Date: 2023-04-18 DOI: 10.1007/s10354-023-01010-y

Dongwon Lee, William Meredith, Benjamin Lebwohl

引用次数: 0

Edwin Klebs : Der k. k. Professor Edwin Klebs – Wegbereiter für Theodor Billroth und Robert Koch – zur 190. Wiederkehr seines Geburtstages. Edwin Klebs : The k. k.埃德温-克莱布教授（Theodor Billroth 和 Robert Koch 的先驱）诞辰 190 周年。

IF 1.1

Wiener medizinische Wochenschrift Pub Date : 2025-03-01 DOI: 10.1007/s10354-024-01036-w

Heinz Flamm

引用次数: 0